2023
DOI: 10.1016/j.jpedsurg.2022.09.042
|View full text |Cite
|
Sign up to set email alerts
|

Morbidity in children after fetoscopic endoluminal tracheal occlusion for severe congenital diaphragmatic hernia: Results from a multidisciplinary clinic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 24 publications
0
7
0
Order By: Relevance
“…A recent meta-analysis found that the survival benefit of FETO is most apparent in care settings where the fetal and neonatal therapy programs operate in an integrated institutional care setting ( 9 ). Given the higher background survival rates for CDH achieved at pediatric high volume centers the benefit of FETO may extend beyond a measurable impact on survival but also decrease respiratory ( 79 ), gastrointestinal as well as neurodevelopmental morbidity ( 80 ). Based on the current level I evidence FETO should be strongly considered for isolated severe left sided CDH, recognizing that the anticipated survival benefit may vary based on care setting and integration with the pediatric management expertise.…”
Section: Fetal Therapy For Cdh By Fetoscopic Tracheal Occlusionmentioning
confidence: 99%
“…A recent meta-analysis found that the survival benefit of FETO is most apparent in care settings where the fetal and neonatal therapy programs operate in an integrated institutional care setting ( 9 ). Given the higher background survival rates for CDH achieved at pediatric high volume centers the benefit of FETO may extend beyond a measurable impact on survival but also decrease respiratory ( 79 ), gastrointestinal as well as neurodevelopmental morbidity ( 80 ). Based on the current level I evidence FETO should be strongly considered for isolated severe left sided CDH, recognizing that the anticipated survival benefit may vary based on care setting and integration with the pediatric management expertise.…”
Section: Fetal Therapy For Cdh By Fetoscopic Tracheal Occlusionmentioning
confidence: 99%
“…Infants with CDH from all racial and ethnic categories were admitted to the ICU for a comparable number of days ( [SD] 14 [28] days vs Black: 18 [37] days; difference, −5 days; 95% CI for difference −9 to −.2; P = .04).…”
Section: Hospital Coursementioning
confidence: 99%
“…Failed embryonic closure of the diaphragm in affected fetuses results in intrathoracic abdominal viscera herniation and varying degrees of pulmonary hypoplasia, pulmonary hypertension, and cardiac dysfunction at birth . Prenatally diagnosed cases require increased surveillance and, in the most severe cases, fetal endoscopic tracheal occlusion has been shown to improve survival with acceptable long-term morbidity . In the majority of patients, survival is improved with delivery at high-volume, designated CDH centers that have a multidisciplinary care approach and access to adjuvant therapies, including extracorporeal life support (ECLS) .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The technique of FETO involves the insertion of an inflatable balloon into the fetal trachea4 to achieve temporary tracheal occlusion. Two RCTs7 8 and many observational studies and systematic reviews9–12 have reported the benefits of FETO, although some experts have cautioned against the widespread implementation of FETO in Extracoporeal membrane oxygenation (ECMO) centres because aggressive postnatal management with early ECMO can achieve very good outcomes even in severe CDH 13…”
Section: Introductionmentioning
confidence: 99%